Apyx Medical Business Summary

Apyx Medical Corporation (NASDAQ: APYX) is a medical technology leader specializing in helium plasma and radiofrequency (RF) energy solutions for the surgical aesthetics market. The company operates through two primary segments: Surgical Aesthetics (formerly Advanced Energy) and Original Equipment Manufacturing (OEM). Revenue is generated through a razor-and-blade model, combining the sale of capital equipment—specifically the Renuvion and J-Plasma generators and the newly launched AYON Body Contouring System—with high-margin, recurring sales of single-use handpieces and accessories. Apyx has strategically pivoted to capitalize on the surging demand for skin-tightening procedures following GLP-1-induced weight loss, positioning its AYON platform as an all-in-one surgical solution for fat removal and tissue contraction. Its primary direct competitors include InMode Ltd., Cutera, Inc., Cynosure, and Allergan Aesthetics (AbbVie); Apyx differentiates itself as the sole provider of proprietary Helium Plasma Technology, which offers superior thermal precision and safety for subdermal tissue coagulation compared to traditional bipolar RF devices. The company is led by President and CEO Charles "Charlie" D. Goodwin, who joined in 2017 following senior leadership roles at Medtronic and Olympus, where he oversaw significant growth in surgical and aesthetic divisions. The executive team was further strengthened by the appointment of Matthew Hill as CFO in late 2023 and Stavros Vizirgianakis as Executive Chairman in May 2024, the latter bringing deep sector expertise as the former CEO of Misonix. Co-founder Andrew Makrides, who served as Chairman for over 40 years, retired in 2024, marking a full transition to the current growth-oriented leadership. Apyx maintains a strong institutional investor base, with approximately 55% of shares held by entities such as Great Point Partners and other healthcare-focused funds, providing the capital necessary for the global commercial expansion of its AYON and Renuvion product lines.